MATAWAN, N.J. & SEOUL - MindWave Innovations Inc., a subsidiary of Apimeds Pharmaceuticals US Inc. (NYSE American:APUS), stated that Inscobee Inc. (KS:006490) and certain stockholders filed an ...
Dharwad: A collective of eminent scientists, management experts and thought leaders has come together with a common vision to train and empower teachers through a new initiative titled Mindwave Edu ...
Practical strategies for turning tutorials into active, inclusive learning spaces, from designing hands-on activities and valuing student contributions to building rapport and providing effective ...
MATAWAN, N.J.--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) today announced the closing of its previously announced $100 million private investment in public equity (PIPE) ...
Apimeds Pharmaceuticals and MindWave Innovations have signed a merger agreement that unites late-stage biotech development with AI-driven Bitcoin treasury infrastructure. Supported by a PIPE of up to ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
MATAWAN, N.J. - Apimeds Pharmaceuticals US, Inc. (NYSE American:APUS) announced Monday it has signed a merger agreement with MindWave Innovations Inc., creating a company that combines ...
Apimeds Pharmaceuticals US, Inc. (APUS) announced a merger with MindWave Innovations Inc, uniting Apimeds’ late-stage, non-opioid pain-management biologic portfolio ...
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced a merger with MindWave Innovations Inc, uniting Apimeds’ late-stage, non-opioid pain-management biologic portfolio with MindWave’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results